Click image to view full size image
Velpatasvir intermediate
(2S,4S)-4-(Methoxymethyl)-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) ester
Density 1.2±0.1 g/cm3
Boiling Point 371.2±27.0 °C at 760 mmHg
Molecular Formula C12H21NO5
Molecular Weight 259.299
Flash Point 178.3±23.7 °C
Use:
(2S,4S)-1-(tert-butoxycarbonyl)-4-(methoxymethyl)pyrroline-2-carboxylic acid is an antiviral agent and a velpatasvir intermediate. Velpatasvir intermediates are NS5A inhibitors in patients with hepatitis C (HCV) infection.At the same time, its clinical application is not affected by the degree of liver damage in patients, nor does it contain protease inhibitors, very safe, almost applicable to all clinical HCV infection patients.
Specification of Corrugated Polypropylene Sheet:
|
CAS |
1378388-16-9 |
|
Category |
Pharmaceutical Raw Materials, Fine Chemicals |
|
Exact Mass
|
259.141968 |
|
Storage |
Have to stay in the place where is cold and dry |
|
PSA
|
76.07000 |
|
LogP |
0.15 |
|
Vapour Pressure
|
0.0±1.8 mmHg at 25°C |
|
Index of Refraction
|
1.485 |
Product Qualification
Packing and shipping
We offer 3 shipping delivery way.
1. Small sample quantity by Courier like DHL/Fedex require 3-7days.
2. Dozens of kgs or special required by Air require 5-10days.
3. Commercial quantity in tonnage by Sea require 10-45days.
Why choose us
Cool Pharm Ltd, found in 2021,is a high-tech enterprise which provides customer synthesis service for domestic and international pharmaceutical companies according to international standards. Our business includes research , development, process optimization and production of APIs and key pharmaceutical intermediates. We also specialize in customer design and synthesis of fine chemicals from lab scale. As a customer focused company, we dedicate in serving the global pharmaceutical industry with seamless custom and efficient solutions.we sincerely hope to cooperate with you for a long time.We specializes in the process R&D, process modification and optimization, scaleup and production of API and intermediates.We can provide customers with integrated, cost-effective and process-efficient services from clinical stage to commercial production. Aiming to help global customers to reduce cost on drug research & development as well as the production
http://www.covapharm.com/